Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis

Next Previous
X
Search
Trial Profile

Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tofacitinib (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Pfizer

    • Most Recent Events

    • 15 Jun 2024 Results assessing tofacitinib long-term safety in Japanese patients (pts) with RA in a 3-year, all-case PMS study, presented at the 25th Annual Congress of the European League Against Rheumatism.
    • 24 Oct 2018 Interim analysis results (data cut off date: 5 Nov 2017; n=3929) assessing incidence of serious infection events in patients with rheumatoid arthritis receiving tofacitinib, presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.
    • 24 Oct 2018 Interim analysis results of safety data (data-cut off date: 5 Nov 2017 (6 month), n=3929) from this trial, presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top